ABIONYX Pharma is Pharmaceuticals in France that focus on drug delivery platform business. Founded in 2005. They cover business area such as Abionyx Pharma, development, innovative therapy, patient, existing or effective treatment, CERENIS Therapeutics, a portfolio, valuable program, cardiovascular disease, associate metabolic disease, NAFLD, NASH, an HDL target drug delivery platform, oncology, chemotherapy.
2005
( 19 years old in 2024 )
Drug Delivery Platform
-
33 43 avenue Georges Pompidou Bât. D2
31130 Balma
France
Private
Abionyx Pharmadevelopmentinnovative therapypatientexisting or effective treatmentCERENIS Therapeuticsa portfoliovaluable programcardiovascular diseaseassociate metabolic diseaseNAFLDNASHan HDL target drug delivery platformoncologychemotherapy
* We use standard office opening hours in near ABIONYX Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ABIONYX Pharma is Pharmaceuticals business from France that founded in 2005 (19 years old in 2024), ABIONYX Pharma business is focusing on Drug Delivery Platform.
ABIONYX Pharma headquarter office and corporate office address is located in 33 43 avenue Georges Pompidou Bât. D2 31130 Balma France.
ABIONYX Pharma was founded in France.
In 2024, ABIONYX Pharma is currently focus on drug delivery platform sector.
Above is snippet of Google Trends for "drug delivery platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ABIONYX Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
